References
- World Health Organization. Human papillomavirus vaccines: WHO position paper. Weekly epidemiological record, 24 October 2014, 89th Year; 89:465-92. http://www.who.int/wer/2014/wer8943.pdf?ua=1
- Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 2007; 56:1-24; PMID:17380109
- Whitney CG, Zhou F, Singleton J, Schuchat A. Benefits from immunization during the vaccines for children program era - United States, 1994-2013. MMWR Morb Mortal Wkly Rep 2014; 63:352-5; PMID:24759657
- Donovan B, Franklin N, Guy R, Grulich AE, Regan DG, Ali H, Wand H, Fairley CK. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis 2011; 11:39-44; PMID:21067976; http://dx.doi.org/10.1016/S1473-3099(10)70225-5
- Ali H, Donovan B, Wand H, Read TR, Regan DG, Grulich AE, Fairley CK, Guy RJ. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. BMJ 2013; 346:f2032; PMID:23599298; http://dx.doi.org/10.1136/bmj.f2032
- Binagwaho A, Wagner CM, Gatera M, Karema C, Nutt CT, Ngabo F. Achieving high coverage in Rwanda's national human papillomavirus vaccination programme. Bull World Health Organ 2012; 90:623-8; PMID:22893746; http://dx.doi.org/10.2471/BLT.11.097253
- Barbaro B, Brotherton JM. Measuring HPV vaccination coverage in Australia: comparing two alternative population-based denominators. Aust N Z J Public Health 2015; 39:326-30; PMID:26094817; http://dx.doi.org/10.1111/1753-6405.12372
- Flaherty DK. The vaccine-autism connection: a public health crisis caused by unethical medical practices and fraudulent science. Ann Pharmacother 2011; 45:1302-4; PMID:21917556; http://dx.doi.org/10.1345/aph.1Q318